All recalls8,436 total
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Salsa products are recalled due to potential contamination with wood particles.
Salsa products are recalled due to potential contamination with wood particles.
Salsa products are recalled due to potential contamination with wood particles.
Salsa products are recalled due to potential contamination with wood particles.
Salsa products are recalled due to potential contamination with wood particles.
Salsa products are recalled due to potential contamination with wood particles.
Product contains undeclared wheat.
Salsa products are recalled due to potential contamination with wood particles.
Salsa products are recalled due to potential contamination with wood particles.
Presence of Particulate Matter
Product is contaminated with Listeria monocytogenes.
Product contains elevated levels of lead (0.0649 mg/kg)
Potential for contamination with salmonella.
Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.
Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..
Lack of Assurance of Sterility
Firm's salsa product was potentially manufactured with a recalled ingredient (Fresh Cilantro containing foreign objects "wood pieces")
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil, propoxyphenylsildenafil, and sildenafil.
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
Glass fragments found in finished product.
Glass fragment found on top of bread.
Firm is recalling product due to the potential of foreign material (glass)
Glass fragment found on top of bread.
Glass fragment found on top of bread.
Contains undeclared allergens (almonds).
Foreign material (foil) found in cake slices
Foreign material (foil) found in cake slices
Field action to clarify the flow rates and inlet fluid temperatures, along with location of the outlet temperature for Ranger Blood/Fluid Warming High Flow Sets.
Product does not declare the allergen, milk, on the label.
Foreign Object - Wood. The firm was notified by their supplier that the product may contain pieces of wood.
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.